Drugs / GSK Biologicals' DTPa-IPV/Hib vaccine
last change Jul 2011 re-read 2 minutes ago

GSK Biologicals' DTPa-IPV/Hib vaccine

Vaccine

Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00466947 Jun 2007 → Aug 2010 streptococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK Biologicals' DTPa-IPV/Hib vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00466947
Modality Vaccine “GSK Biologicals' DTPa-IPV/Hib vaccineNCT00466947